Sub400” is a new CXL protocol developted at here at ELZA, that has been successfully used to cross-link KC corneas as thin as 220 µm – without “hacks.
Important innovation in measuring success after cross-linking for keratoconus. Prof. Farhad Hafezi from the ELZA Institute in Switzerland shows the new biomechanics CorVis display.
Podium Power: Dion Paridaens gives EUGOGO Keynote Lecture: Nanotechnology in the Treatment of Eye Disease…
ELZA’s Medical Director, Prof. Farhad Hafezi was an invited international guest speaker at the recent 13th Congrès D’Ophthalmologique Practique (AOPA) at the Hotel Sheraton Alger in Algiers. The congress covered all of ophthalmology, but had a large cornea and refractive sessions, where Prof. Hafezi gave presentations on ELZA’s current research work. His podium presentations reviewed ELZA’s research into refractive surgery, corneal cross-linking and PACK-CXL for the treatment of corneal infection. He also celebrated his birthday while attending the congress!
Prof. Hafezi was invited to give a series of four presentations at the 9th Congrès de la Vision in Rabat, Morocco
Why do stars sometimes “twinkle” in the sky? Atmospheric turbulence: the light that comes from the star gets distorted by particles in the atmosphere. It is the same with light entering the eye
Farhad Hafezi was interviewed during ESCRS 2019, held in Paris, France, by Touch Medical Media on how CXL is performed at the slit lamp.
Prof. Farhad Hafezi, Medical Director of the ELZA Institute in Zurich, Switzerland, had the honor of delivering the prestigious Whitney G Sampson lecture on Sunday, October 13th, 2019 at the annual conference of American Academy of Ophthalmology (AAO) in San Francisco, California.
The annual meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) was held in Paris between 14–18 September 2019, and ELZA’s surgeons and researchers presented a record 21 presentations during the congress – so what did ELZA at ESCRS manage to achieve? Our team presented at 8 free paper presentations and a further 8 instructional courses, as well as three moderated poster sessions, two e-posters (as well as instructing in 1 wet lab too).
A lot has been said about SMILE, some of which has been about how, in theory, corneas treated with SMILE should be biomechanically stronger than LASIK-treated corneas (more of the stronger anterior stroma is left intact compared with physically cutting a flap there in LASIK and lifting it to perform ablation of the stroma underneath). But what about PRK? This is ablation of the anterior stroma after having just removed the epithelial cells above it, on the surface of the cornea. So the question remains: which is stronger? PRK or SMILE? The short answer is that PRK is stronger.
